Protagonist Therapeutics has delivered strong Phase 3 data for both icotrokinra (psoriasis) and rusfertide (polycythemia vera), supporting blockbuster potential. Lucrative partnerships with Johnson & ...

When comparing two sets of omics results, it’s easy to focus on what features overlap. But what if you want to know what makes them distinct? This article walks through an alternative use of Rank-Rank ...